RE: SP re-rate at commencement H Car-T trial and early data…Really!?6 Sep 2024 12:30
Stu
Last week you were pumping this up stating news incoming on either non diluted funds or 2nd site approval. You bought it, it made zero change in share price and you sold off and your new narrative is that comparing other AML pharma stocks and the stating they didnt rise on first injection.
You really are a sad bloke and cannot make your mind up if you should believe in this stock or trash it. Why not just buy in and then shut up and actually support a cancer stock trying to save lifes. You thought the CDX RNS was one of the ones you stated and luckily you were wrong as no insider info was given to you.
As dhub stated, all LTHs have bought in and apart from a few sad traders and shorters, its now a wait game. Next week or next month no one knows and not even vlad since once the decision is in the hands of the hospital and not vlad. Anyways, it would be really nice if u actually bought some shares and held them rather than trying to create FUD with totally irrelevant comparisons.....
This is a stupidly valued company and destroyed by shorters and some bad decisions but like most things on the stock market, some good news will rerate it to normality.